Treatment of hemangioma by embolization

Treatment of giant liver hemangioma by PVA particle embolization with or without bleomycin

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20191105045343N1

Enrollment

Registered

2019-12-16

Start date

2020-01-21

Completion date

Unknown

Last updated

2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Giant liver hemangioma. Hemangioma

Interventions

Intervention 1: Intervention group: Patients with giant liver hemangioma are treated by embolization with PVA particles and intravenous injection of bleomycin with lipiodol. Intervention 2: Control gr

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with giant hemangioma diagnosed by the relevant specialist Patients with clinical signs of hemangioma enlargement

Exclusion criteria

Exclusion criteria: No Patient's consent Patients with INR> 1.5

Design outcomes

Primary

Measure	Time frame
The size of liver hemangioma lesions. Timepoint: Before, immediately after the intervention, one, three, six months after the intervention. Method of measurement: Lesion size by ultrasound, CT scan, MRI.;Liver enzymes. Timepoint: Before, immediately after the intervention, one, three, six months after the intervention. Method of measurement: Liver enzymes in the blood with a special kit.;The amount of pain. Timepoint: Before, immediately after the intervention, one, three, six months after the intervention. Method of measurement: Wong-baker criteria.	—

Measure

Time frame

The size of liver hemangioma lesions. Timepoint: Before, immediately after the intervention, one, three, six months after the intervention. Method of measurement: Lesion size by ultrasound, CT scan, MRI.;Liver enzymes. Timepoint: Before, immediately after the intervention, one, three, six months after the intervention. Method of measurement: Liver enzymes in the blood with a special kit.;The amount of pain. Timepoint: Before, immediately after the intervention, one, three, six months after the intervention. Method of measurement: Wong-baker criteria.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr.Seyed Ali Golestanha

Shahed University

mohammadrhs1373@gmail.com+98 21 4422 3766

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026